Form 4: CVS Health Corp: SVP, Controller & Chief Accounting Officer James David Clark Reports Changes in Beneficial Ownership

James David Clark, SVP, Controller & Chief Accounting Officer of CVS Health Corp, reports changes in beneficial ownership of common stock and restricted stock units due to tax withholdings and new awards.

Summary

• On April 1, 2024, James David Clark, SVP, Controller & Chief Accounting Officer of CVS Health Corp, reported changes in his beneficial ownership of CVS stock.
• He surrendered 1,892 shares at $79.56 per share to cover withholding taxes on vesting restricted stock units, reducing his holdings to 9,592 shares.
• Clark also surrendered 1,112 shares at $79.56 per share to cover withholding taxes on vesting performance stock units, further reducing his holdings to 8,480 shares.
• He was awarded 10,683 restricted stock units at $79.56 per unit, increasing his total holdings to 15,109 shares.
• These restricted stock units vest in four equal installments starting April 1, 2025, under the 2017 Incentive Compensation Plan.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The awarding of 10,683 restricted stock units to James David Clark indicates continued investment in key personnel.
• The vesting schedule of these units, commencing in 2025, suggests a long-term commitment from the executive.

Future Outlook

The restricted stock units awarded will vest in four equal installments commencing on April 1, 2025, suggesting a continued alignment of executive compensation with long-term company performance.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like CVS Health Corp. It provides transparency into the financial incentives of key executives.

Comparison to Industry Standards

• Executive compensation packages including restricted stock units are standard practice among large corporations like CVS Health Corp to incentivize performance and retain key talent.
• Companies such as Walgreens Boots Alliance and UnitedHealth Group also utilize similar equity-based compensation plans for their executives.
• The vesting schedule of the restricted stock units is typical, aligning with industry norms for long-term incentive programs.

Stakeholder Impact

• Shareholders are informed about changes in beneficial ownership by a key executive, providing transparency into management's stake in the company.
• Employees may be interested in the details of the company's incentive compensation plan.

Key Dates